Centric Wealth Management Trims Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Centric Wealth Management lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 44.3% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 4,380 shares of the healthcare conglomerate's stock after selling 3,479 shares during the quarter. Centric Wealth Management's holdings in UnitedHealth Group were worth $2,216,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. NewSquare Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter worth approximately $25,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at $30,000. Promus Capital LLC bought a new position in UnitedHealth Group during the fourth quarter worth $32,000. Pillar Financial Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at $40,000. Finally, DecisionPoint Financial LLC grew its stake in shares of UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock valued at $52,000 after buying an additional 62 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on UNH shares. Cantor Fitzgerald reiterated an "overweight" rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Barclays reduced their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. HSBC raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective on the stock in a research note on Friday, January 10th. Piper Sandler dropped their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. Finally, Oppenheimer increased their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Twenty investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $629.32.

Remove Ads

Insider Activity

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business's stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded up $18.44 during trading on Thursday, hitting $541.64. The stock had a trading volume of 5,018,470 shares, compared to its average volume of 4,239,669. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock's 50 day moving average is $509.15 and its two-hundred day moving average is $542.83. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a market cap of $495.44 billion, a price-to-earnings ratio of 34.97, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm's revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter last year, the firm posted $5.83 EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group's dividend payout ratio is currently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.